Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
29.95
-0.65 (-2.12%)
Aug 27, 2026, 10:33 AM EDT - Market open

Biodesix Revenue

Biodesix had revenue of $26.86M in the quarter ending June 30, 2026, with 34.18% growth. This brings the company's revenue in the last twelve months to $102.94M, up 34.46% year-over-year. In the year 2025, Biodesix had annual revenue of $88.50M with 24.08% growth.

Revenue (ttm)
$102.94M
Revenue Growth
+34.46%
P/S Ratio
3.07
Revenue / Employee
$308,201
Employees
334
Market Cap
316.01M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202588.50M17.18M24.08%
Dec 31, 202471.32M22.24M45.30%
Dec 31, 202349.09M10.88M28.46%
Dec 31, 202238.21M-16.29M-29.89%
Dec 31, 202154.51M8.95M19.64%
Dec 31, 202045.56M21.01M85.55%
Dec 31, 201924.55M4.12M20.16%
Dec 31, 201820.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics806.60M
OPKO Health587.90M
Castle Biosciences357.28M
Fulgent Genetics323.93M
MDxHealth114.02M
Burning Rock Biotech74.58M
Exagen71.12M
Freenome35.41M
Revenue Rankings